Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Thomas

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|July 25, 2020
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapyTorben Rixecker, Vadim Lesan, Manfred Ahlgrimm, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell LymphomaDominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.
Expert Review of Vaccines|August 22, 2022
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2Igor Age Kos, Maximilian Kiefer, Katharina Brill, et al.
Plos One|April 25, 2013
Crystal structure of an anti-Ang2 CrossFab demonstrates complete structural and functional integrity of the variable domainSebastian Fenn, Christian B Schiller, Julia J Griese, et al.
Annals of Hematology|September 3, 2024
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphomaKonstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Vadim Lesan, et al.
European Journal of Haematology|August 1, 2024
Comparison of R-CHOP-14 and R-mini-CHOP in older adults with diffuse large B-cell lymphoma-A retrospective multicenter cohort studyZelal Guel Dilbaz, Sophy Denker, Carla Ankermann, et al.
Scientific Reports|April 26, 2024
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomasMichelle Elbert, Frank Neumann, Maximilian Kiefer, et al.
Anti-Cancer Drugs|May 29, 2004
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracilJoerg Thomas Hartmann, Karin Oechsle, Elke Jäger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study GroupAnja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
International Journal of Molecular Sciences|December 17, 2024
Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular CytotoxicityMoritz Bewarder, Konstantinos Christofyllakis, Milena Petersen, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|July 25, 2020
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapyTorben Rixecker, Vadim Lesan, Manfred Ahlgrimm, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell LymphomaDominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.
Expert Review of Vaccines|August 22, 2022
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2Igor Age Kos, Maximilian Kiefer, Katharina Brill, et al.
Plos One|April 25, 2013
Crystal structure of an anti-Ang2 CrossFab demonstrates complete structural and functional integrity of the variable domainSebastian Fenn, Christian B Schiller, Julia J Griese, et al.
Annals of Hematology|September 3, 2024
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphomaKonstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Vadim Lesan, et al.
European Journal of Haematology|August 1, 2024
Comparison of R-CHOP-14 and R-mini-CHOP in older adults with diffuse large B-cell lymphoma-A retrospective multicenter cohort studyZelal Guel Dilbaz, Sophy Denker, Carla Ankermann, et al.
Scientific Reports|April 26, 2024
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomasMichelle Elbert, Frank Neumann, Maximilian Kiefer, et al.
Anti-Cancer Drugs|May 29, 2004
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracilJoerg Thomas Hartmann, Karin Oechsle, Elke Jäger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study GroupAnja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
International Journal of Molecular Sciences|December 17, 2024
Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular CytotoxicityMoritz Bewarder, Konstantinos Christofyllakis, Milena Petersen, et al.
Pageof 5